Michaelis, M.; Voges, Y.; Rothweiler, F.; Weipert, F.; Zia-Ahmad, A.; Cinatl, J.; von Deimling, A.; Westermann, F.; Rödel, F.; Wass, M.N.;
et al. Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines. Cancers 2020, 12, 577.
https://doi.org/10.3390/cancers12030577
AMA Style
Michaelis M, Voges Y, Rothweiler F, Weipert F, Zia-Ahmad A, Cinatl J, von Deimling A, Westermann F, Rödel F, Wass MN,
et al. Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines. Cancers. 2020; 12(3):577.
https://doi.org/10.3390/cancers12030577
Chicago/Turabian Style
Michaelis, Martin, Yvonne Voges, Florian Rothweiler, Fabian Weipert, Amara Zia-Ahmad, Jaroslav Cinatl, Andreas von Deimling, Frank Westermann, Franz Rödel, Mark N. Wass,
and et al. 2020. "Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines" Cancers 12, no. 3: 577.
https://doi.org/10.3390/cancers12030577
APA Style
Michaelis, M., Voges, Y., Rothweiler, F., Weipert, F., Zia-Ahmad, A., Cinatl, J., von Deimling, A., Westermann, F., Rödel, F., Wass, M. N., & Cinatl, J., Jr.
(2020). Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines. Cancers, 12(3), 577.
https://doi.org/10.3390/cancers12030577